Ara mostrant els elements 1-15 de 15

    • Adverse drug events in patients with dementia and neuropsychiatric/behavioral, and psychological symptoms, a one-year prospective study 

      Mestres Miralles, Concepción; Modamio Charles, Pilar; Junyent, Jaume; Costa Tutusaus, Lluís; Fernández Lastra, Cecilia; Mariño Hernández, Eduardo L.; Hernández Hernández, Marta (International journal of environmental research and public health, 2019, vol. 16, núm. 6, 2019-03)
      Older people usually present with adverse drug events (ADEs) with nonspecific symptoms such as cognitive decline, recurrent falls, reduced mobility, and/or major deterioration. The aims of this study ...
    • Anticholinergic burden and safety outcomes in older patients with chronic hepatitis C: A retrospective cohort study 

      Amorós-Reboredo, Patrícia; Soy Muner, Dolors; Hernández Hernández, Marta; Lens, Sabela; Mestres Miralles, Concepción (International Journal of Environmental Research and Public Health, 2020, vol. 17, núm. 11, 2020-05)
      Aim: Older patients with chronic hepatitis C infection starting direct-acting antivirals (DAAs) are frequently prescribed multiple medications that may be categorized as inappropriate. Anticholinergic ...
    • CES1 and SLC6A2 genetic variants as predictors of response to methylphenidate in autism spectrum disorders 

      Hernández Hernández, Marta; Bote, Valentin; Serra-Llovich, Alexandre; Cendros, Marc; Salazar, Juliana; Mestres Miralles, Concepción; Guijarro, Silvina; Alvarez, Aida; Lamborena, Cristina; Mendez, Iria; Sánchez, Bernardo; Hervas, Amaia; Arranz, Maria J (Pharmacogenomics and personalized medicine, 2022, vol. 15, p. 951-957, 2022-11)
      Purpose Autistic spectrum disorders (ASD) children and adolescents usually present comorbidities, with 40–70% of them affected by attention deficit hyperactivity disorders (ADHD). The first option of ...
    • Clinical impact of electronic monitoring devices of inhalers in adults with asthma or COPD: a systematic review and meta-analysis 

      Garin, Noe; Zarate-Tamames, Borja; Gras-Martin, Laura; Milà, Raimon; Crespo-Lessmann, Astrid; Curto, Elena; Hernández Hernández, Marta; Mestres Miralles, Concepción; Plaza Moral, Vicente (Pharmaceuticals, 2023, vol. 16, núm. 3, 414, 2023-03)
      We conducted a systematic review and meta-analysis to gain insight into the characteristics and clinical impact of electronic monitoring devices of inhalers (EMDs) and their clinical interventions in ...
    • Development of a pharmaceutical care program in progressive stages in geriatric institutions 

      Mestres Miralles, Concepción; Hernández Hernández, Marta; Agustí, Anna; Puerta, Laura; Llagostera, Blanca; Amorós-Reboredo, Patrícia (BMC Geriatrics, 2018, vol. 18, núm. 316, 2018-12)
      Background: To introduce and manage a Pharmaceutical care programs in geriatric care institutions presents difficulties such as reduced pharmacy service staff, complexity of the patients or lack of ...
    • Effects of a multifaceted intervention in psychogeriatric patients: one-year prospective study 

      Hernández Hernández, Marta; Mestres Miralles, Concepción; Junyent, Jaume; Costa-Tutusaus, Lluís; Modamio Charles, Pilar; Fernández Lastra, Cecilia; Mariño Hernández, Eduardo L. (European Journal of Hospital Pharmacy, 2020, 27:226-231, 2020-06)
      Objectives The aetiology of behavioural and psychological symptoms (BPSD) could be related to inadequate treatment in patients with dementia. The aim of this study was to determine how a multifaceted ...
    • Fine-tuning formulation and biological interaction of doxorubicin-loaded polymeric nanoparticles via electrolyte concentration modulation 

      Bofill Bonet, Carles; Gil Vives, Maria; Artigues Cladera, Margalida; Hernández Hernández, Marta; Borrós i Gómez, Salvador; Fornaguera Puigvert, Cristina (Journal of Molecular Liquids, 2023, vol. 390, part A, 122986, 2023-09)
      Doxorubicin (DOX) is amongst the most widely used chemotherapeutic drugs against various cancers. However, its controlled biodistribution to the tumor site at the required pharmacokinetics profile ...
    • Optimització de la resistència a antiinfecciosos en la pràctica clínica 

      Bascones, M.; Llompart, A.; Hernández Hernández, Marta; Mestres Miralles, Concepción (Circular farmacèutica, 2021, vol. 79, núm. 1, p. 21-23, 2021)
      Avaluar la idoneïtat de la prescripció d’antibacterians en la gestió clínica de les infeccions bacterianes en un establiment sanitari privat amb una alta rotació de facultatius, per tal de contribuir ...
    • Parental genetically predicted liability for coronary heart disease and risk of adverse pregnancy outcomes: a cohort study 

      Hernáez, Álvaro; Skåra, Karoline Hansen; Page, Christian Magnus; Mitter, Vera R.; Hernández Hernández, Marta; Magnus, Per; Njølstad, Pål R.; Andreassen, Ole A.; Corfeld, Elizabeth C.; Havdahl, Alexandra; Næss, Øyvind; Brumpton, Ben; Åsvold, Bjørn Olav; Lawlor, Deborah A.; Fraser, Abigail; Magnus, Maria Christine (BMC Medicine, 2024, 22:35, 2024-01)
      Background Adverse pregnancy outcomes (APO) may unmask or exacerbate a woman’s underlying risk for coronary heart disease (CHD). We estimated associations of maternal and paternal genetically predicted ...
    • Pharmacist intervention program at different rent levels of geriatric healthcare 

      Mestres Miralles, Concepción; Agustí, Anna; Hernández Hernández, Marta; Puerta, Laura; Llagostera, Blanca (Pharmacy, 2017, vol. 5, núm. 2, 2017-05)
      As a pharmacy service giving pharmaceutical care at different levels of health care for elderly people, we needed a standardization procedure for recording and evaluating pharmacists’ interventions. Our ...
    • Pharmacogenetic influences on the response to pharmacological treatment in autism spectrum disorders 

      Hervas, Amaia; Serra-Llovich, Alexandre; Rueda, Isabel; Targa, Irene; Guijarro, Silvina; Bigorra, Aitana; Cancino, Martha; Bote, Valentin; Cárcel, María; Amasi-Hartoonian, Nare; Hernández Hernández, Marta; Arranz, Maria J (Journal of Translational Genetics and Genomics, 2021, 5:278-287, 2021-07)
      Aim: About a third of patients with autism spectrum disorder (ASD) receive pharmacological treatment for comorbid symptoms. However, 30%-50% do not respond adequately and/or present severe and long-lasting ...
    • Pharmacogenetic interventions improve the clinical outcome of treatment-resistant autistic spectrum disorder sufferers 

      Arranz, Maria J; Salazar, Juliana; Bote, Valentin; Artigas-Baleri, Alícia; Serra-Llovich, Alexandre; Triviño, Emma; Roige, Jordi; Lombardia, Carlos; Cancino, Martha; Hernández Hernández, Marta; Cendros, Marc; Duran-Tauleria, Enric; Maraver, Natalia; Hervas, Amaia (Pharmaceutics, 2022, 14 (5), 999, 2022-05)
      BACKGROUND: Autistic spectrum disorders (ASD) are severe neurodevelopmental alterations characterised by deficits in social communication and repetitive and restricted behaviours. About a third of ...
    • Pharmacogenetics of antipsychotics: clinical utility and implementation 

      Arranz, Maria J; Salazar, Juliana; Hernández Hernández, Marta (Behavioural Brain Research, 2021, vol. 401, 113058, 2020-12)
      Decades of research have produced extensive evidence of the contribution of genetic factors to the efficacy and toxicity of antipsychotics. Numerous genetic variants in genes controlling drug availability ...
    • Programa de coordinación en la transición asistencial para la mejora de la farmacoterapia entre un Servicio de Urgencias y un Centro Sociosanitario 

      Ruiz-Ramos, Jesús; Amorós-Reboredo, Patrícia; Puerta, Laura; Juanes Borrego, Ana; El Hilali Maso, N.; Hernández Hernández, Marta; Mangues-Bafalluy, Maria A. (Revista de la OFIL = ILAPHAR, 2022, vol. 32, núm. 2, p. 163-166, 2022)
      Objetivos: Describir un programa de colaboración entre farmacéuticos de un Servicio de Urgencias y un Centro sociosanitario, así como evaluar su impacto sobre la frecuencia de reconsulta al Servicio de ...
    • The Impact of pharmaceutical care in multidisciplinary teams on health outcomes: systematic review and meta-analysis 

      Ruiz-Ramos, Jesús; Hernández Hernández, Marta; Juanes Borrego, Ana; Milà, Raimon; Mangues-Bafalluy, Maria A.; Mestres Miralles, Concepción (Journal of the American Medical Directors Association (JAMDA), 2021, vol. 22, núm. 12, p. 2518-2526, 2021-07)
      Objectives Pharmacists’ care has an essential role in multidisciplinary teams in charge of chronic patients. However, data available on the clinical outcomes of these activities appear inconclusive. ...